The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jan. 30, 2024

Filed:

Apr. 24, 2019
Applicants:

The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., Bethesda, MD (US);

The Beth Israel Deaconess Medical Center, Inc., Boston, MA (US);

The Government of the United States As Represented BY the Secretary of the Army, Silver Spring, MD (US);

Inventors:

Shelly Krebs, Bethesda, MD (US);

Gina Donofrio, Rockville, MD (US);

Vincent Dussupt, Silver Spring, MD (US);

Kayvon Modjarrad, Bethesda, MD (US);

Dan Barouch, Boston, MA (US);

Richard G. Jarman, III, Silver Spring, MD (US);

Nelson L. Michael, Silver Spring, MD (US);

Gordon Joyce, Silver Spring, MD (US);

Rajeshwer Singh Sankhala, Silver Spring, MD (US);

Kathryn Elaine Stephenson, Boston, MA (US);

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C07K 16/10 (2006.01); A61P 31/14 (2006.01); A61K 39/12 (2006.01); C12N 7/00 (2006.01); G01N 33/563 (2006.01); G01N 33/569 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
C07K 16/1081 (2013.01); A61K 39/12 (2013.01); A61P 31/14 (2018.01); C12N 7/00 (2013.01); G01N 33/563 (2013.01); G01N 33/56983 (2013.01); A61K 2039/505 (2013.01); A61K 2039/5252 (2013.01); C07K 2317/21 (2013.01); C07K 2317/24 (2013.01); C07K 2317/31 (2013.01); C07K 2317/55 (2013.01); C07K 2317/565 (2013.01); C07K 2317/622 (2013.01); C07K 2317/76 (2013.01); C07K 2317/92 (2013.01); C12N 2770/24134 (2013.01);
Abstract

The invention described herein provides antibodies to Zika virus. The novel polypeptides are useful alone or as portions of larger molecules, such as antibodies or antibody fragments, that can be used to treat or prevent infection of Zika virus.


Find Patent Forward Citations

Loading…